ホーム › 急性骨髄性白血病 › フロリダ州 › Jacksonville
Jacksonville、FLにおける急性骨髄性白血病の臨床試験
Jacksonvilleとその周辺地域(約30マイル以内)の拠点で、急性骨髄性白血病に関する13件の研究が参加者を募集しています。研究を開いて、参加資格と連絡方法を確認してください。
公式研究テキスト(英語)
ここで研究参加者を募集していますか? このページの上部に表示できます — 30日間 $99 →
MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)
被験者募集中第2相
- Mayo Clinic in Florida, Jacksonville
Testing New Therapies for Patients With Acute Myeloid Leukemia Who Are Newly Diagnosed and Have Not Yet Started Treatment (A MyeloMATCH Treatment Trial)
被験者募集中第2相
- Mayo Clinic in Florida, Jacksonville
A Study to Compare Standard Chemotherapy to Therapy With CPX-351 and/or Gilteritinib for Patients With Newly Diagnosed AML With or Without FLT3 Mutations
被験者募集中第3相
- Nemours Children's Clinic-Jacksonville, Jacksonville
Xylitol Dental Wipes for the Reduction of Bloodstream Infection Risk in Children With Acute Myeloid Leukemia
被験者募集中第3相
- Nemours Children's Clinic-Jacksonville, Jacksonville
Study of SLS009 (Formerly GFH009) a Potent Highly Selective CDK9 Inhibitor in Patients With Hematologic Malignancies and High-Risk Newly Diagnosed AML
被験者募集中第1/2相
- Mayo Clinic, Jacksonville
Revumenib in Combination With Azacitidine + Venetoclax in Patients NPM1-mutated or KMT2A-rearranged AML
被験者募集中第3相
- US-Jacksonville FL-MAYOFL, Jacksonville
The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study
被験者募集中第1/2相
- Nemours Children's Clinic-Jacksonville, Jacksonville
Venetoclax in Children With Relapsed Acute Myeloid Leukemia (AML)
被験者募集中第3相
- Nemours Children's Specialty Care Jacksonville, Jacksonville
A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)
被験者募集中観察研究
- Nemours Children's Hospital - Mayo Jacksonville, Jacksonville
A Study of CTX-712 in Relapsed/Refractory Acute Myeloid Leukemia and Higher Risk Myelodysplastic Syndromes
被験者募集中第1/2相
- Mayo Clinic Florida, Jacksonville
Immune Profile of Acute Myeloid Leukemia Patients Receiving Azacitidine Plus Venetoclax Induction Chemotherapy
被験者募集中観察研究
- Mayo Clinic in Florida, Jacksonville
A Study to Investigate the Safety and Tolerability of Ziftomenib in Combination With Venetoclax/Azacitidine, Venetoclax, 7+3, or 7+3+Quizartinib in Patients With AML
被験者募集中第1相
- Mayo Clinic Jacksonville, Jacksonville
Study in Relapsed/Refractory Acute Myeloid Leukemia or Myelodysplastic Syndrome Patients to Determine the Recommended Dose of CYAD-02
被験者募集中第1相
- Mayo Clinic Cancer Center, Jacksonville
他の都市における急性骨髄性白血病の試験
- Houston, TX85件の研究
- New York City, NY51件の研究
- Boston, MA44件の研究
- Seattle, WA41件の研究
- Baldwin Park, CA40件の研究
- Columbus, OH35件の研究
- Philadelphia, PA34件の研究
- Durham, NC33件の研究
- Atlanta, GA31件の研究
- Tampa, FL29件の研究
- Chicago, IL26件の研究
- Portland, OR25件の研究
Jacksonvilleにおける他の研究
- 乳がん40件の研究
- 非小細胞肺癌39件の研究
- がん(全種類)29件の研究
- 転移性癌28件の研究
- 大腸癌27件の研究
- 前立腺がん26件の研究
- 肥満症25件の研究
- 心不全21件の研究
- 膵臓がん20件の研究
- 過体重19件の研究
- 多発性骨髄腫18件の研究
- 肺がん17件の研究
ClinicalTrials.govより、2026/10/06時点のデータを取得。各研究には独自の参加資格があり、参加可否は研究チームが決定します。